{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-311947","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2022-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.782342+00:00","generated_at":"2026-06-20T23:06:03.180700+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"First Light Acquisition Group co-CEO Bill Weber resigns; Thomas Vecchiolla becomes sole CEO and Chairman","bullets":["Bill Weber resigned as co-CEO, Director, and Chairman effective Dec 21, 2022; no disagreement cited.","Thomas A. Vecchiolla appointed sole CEO and Chairman, effective Dec 22, 2022.","Weber's departure reduces leadership to a single CEO structure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-311947","json":"https://secwatch.observer/filing/0001193125-22-311947.json","markdown":"https://secwatch.observer/filing/0001193125-22-311947.md","text":"https://secwatch.observer/filing/0001193125-22-311947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000119312522311947/0001193125-22-311947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000119312522311947/d421264d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:06:03.180700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d4e690839b","claim":"Bill Weber resigned as co-Chief Executive Officer, Director and Chairman of the Board at Calidi Biotherapeutics, Inc..","evidence_excerpt":"On December 21, 2022, Bill Weber resigned from his position as co-Chief Executive Officer, Director and Chairman of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855485/000119312522311947/0001193125-22-311947-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"co-Chief Executive Officer, Director and Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"d99a3f9fba","claim":"Thomas A. Vecchiolla was appointed as sole Chief Executive Officer and Chairman of the Board at Calidi Biotherapeutics, Inc..","evidence_excerpt":"Effective as of December 22, 2022, Thomas A. Vecchiolla will serve as sole Chief Executive Officer and Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855485/000119312522311947/0001193125-22-311947-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"sole Chief Executive Officer and Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}